Researchers reveal a strategy for next-generation COVID-19 vaccines

A study led by the Garvan Institute of Medical Research has revealed a guide to developing COVID-19 vaccines that both prevent the coronavirus from infecting human cells and that are more resistant to evolving viral strains. The team’s key criteria for antibodies generated by future vaccines are to target regions of the SARS-CoV-2 viral surface that are unlikely to mutate and share key features that the researchers found could block the virus from infecting human cells.
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news